DZ2519A1 - Pharmaceutical compositions comprising an insulin sensitizer and an antihyperglycemic agent for a method of treating diabetes. - Google Patents

Pharmaceutical compositions comprising an insulin sensitizer and an antihyperglycemic agent for a method of treating diabetes.

Info

Publication number
DZ2519A1
DZ2519A1 DZ980129A DZ980129A DZ2519A1 DZ 2519 A1 DZ2519 A1 DZ 2519A1 DZ 980129 A DZ980129 A DZ 980129A DZ 980129 A DZ980129 A DZ 980129A DZ 2519 A1 DZ2519 A1 DZ 2519A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
treating diabetes
insulin sensitizer
antihyperglycemic agent
antihyperglycemic
Prior art date
Application number
DZ980129A
Other languages
French (fr)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2519A1 publication Critical patent/DZ2519A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
DZ980129A 1997-06-18 1998-06-17 Pharmaceutical compositions comprising an insulin sensitizer and an antihyperglycemic agent for a method of treating diabetes. DZ2519A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method

Publications (1)

Publication Number Publication Date
DZ2519A1 true DZ2519A1 (en) 2003-02-01

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980129A DZ2519A1 (en) 1997-06-18 1998-06-17 Pharmaceutical compositions comprising an insulin sensitizer and an antihyperglycemic agent for a method of treating diabetes.

Country Status (24)

Country Link
EP (1) EP0975343A1 (en)
JP (1) JP2001523271A (en)
KR (1) KR20010013845A (en)
CN (1) CN1274282A (en)
AP (1) AP9901720A0 (en)
AR (2) AR013352A1 (en)
AU (1) AU8799998A (en)
BG (1) BG103966A (en)
BR (1) BR9810186A (en)
CA (1) CA2294134A1 (en)
CO (1) CO4940453A1 (en)
DZ (1) DZ2519A1 (en)
EA (1) EA200000040A1 (en)
IL (1) IL133138A0 (en)
MA (1) MA26510A1 (en)
NO (1) NO996270L (en)
NZ (1) NZ501345A (en)
OA (1) OA11631A (en)
PE (1) PE89199A1 (en)
PL (1) PL337577A1 (en)
SK (1) SK179499A3 (en)
TR (1) TR199903072T2 (en)
UY (1) UY25051A1 (en)
WO (1) WO1998057635A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200103061T2 (en) 1999-04-23 2002-05-21 Smithkline Beecham P.L.C. New pharmaceutical ingredient.
WO2002080936A1 (en) 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
JP4590158B2 (en) 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Combination therapy comprising a glucose reabsorption inhibitor and a retinoid-X receptor modulator
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
JP2004067575A (en) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd Promoter for effect of therapeutic agent for diabetes
CN101121004B (en) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 Medicine composition containing insulin intensifier and miglitol
CN101584705B (en) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 Medicament composition for treating diabetes and complications of diabetes
CN101584688B (en) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 Medicament composition for treating diabetes and complications of diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AU8799998A (en) 1999-01-04
WO1998057635A1 (en) 1998-12-23
AR014881A1 (en) 2001-04-11
JP2001523271A (en) 2001-11-20
IL133138A0 (en) 2001-03-19
BR9810186A (en) 2000-08-08
UY25051A1 (en) 2000-09-29
EP0975343A1 (en) 2000-02-02
CN1274282A (en) 2000-11-22
MA26510A1 (en) 2004-12-20
PE89199A1 (en) 1999-10-23
NO996270D0 (en) 1999-12-17
NO996270L (en) 1999-12-17
CA2294134A1 (en) 1998-12-23
AR013352A1 (en) 2000-12-27
OA11631A (en) 2004-11-22
BG103966A (en) 2000-07-31
KR20010013845A (en) 2001-02-26
TR199903072T2 (en) 2000-07-21
NZ501345A (en) 2001-10-26
PL337577A1 (en) 2000-08-28
CO4940453A1 (en) 2000-07-24
AP9901720A0 (en) 1999-12-31
SK179499A3 (en) 2000-11-07
EA200000040A1 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
DZ2520A1 (en) Pharmaceutical composition for a method of treating diabetes mellitus.
DZ2519A1 (en) Pharmaceutical compositions comprising an insulin sensitizer and an antihyperglycemic agent for a method of treating diabetes.
FR2714505B1 (en) Device and method for generating an image intended for three-dimensional computer graphics processing.
DZ2539A1 (en) Pharmaceutical compositions for the treatment of insulin resistance.
NO973489D0 (en) Stabilized gas emulsion containing phospholipid for contrast enhancement in ultrasound examinations
TNSN96104A1 (en) (1S, 2S) -1- (4-HYDROXYPHENYL) -2- (4-HYDROXY-4-PHENYLPIPERIDINE-1-YL) -1-PROPANOL TRIHYDRATE METAHENSULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
MX9703380A (en) Computer system for data management and method for operating said system.
FR2707788B1 (en) Method and apparatus for reducing discontinuities in an active addressing display system.
DZ2521A1 (en) Pharmaceutical compositions comprising 5-Ä4-Ä2- (methyl-n- (2-pyridyl) amino) ethoxyÜbenzylÜ-thiazolidine-2,4-dione and insulin for a method of treatment.
FR2716075B1 (en) A method for enhancing the effectiveness of an agricultural chemical, enhancer and enhancer composition used in this method and agricultural chemical composition comprising this enhancer.
DE69003638D1 (en) DEVELOPER FOR STATIC LOADING IMAGES.
DZ2522A1 (en) Composition comprising an insulin sensitizer and insulin secretagogue for a method of treatment.
FR2717000B1 (en) Peripheral device with keyboard and screen for computer.
MA21586A1 (en) PROCESS FOR THE PREPARATION OF A NEW SUSTAINED-RELEASE PHARMACEUTICAL FORM COMPRISING AN ACTIVE PRINCIPLE RESIN COMPLEX.
DE69625315D1 (en) Photosensitive silver halide emulsions and process for their preparation
FR2643474B1 (en) DEVICE FOR RECORDING AN EXECUTION HISTORY IN AN INFORMATION PROCESSING UNIT
FR2737028B1 (en) APPLICATION DRESSING ARCHITECTURE FOR A COMPUTER PLATFORM
MA26522A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SUGAR DIABETES AND RELATED CONDITIONS.
HUP0003626A2 (en) Pharmaceutical composition for treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
FR2701892B1 (en) METHOD AND DEVICE FOR PERFORMING WORKING STEPS IN A CYLINDER OF A PRINTING MACHINE.
FR2848454B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ASSOCIATION OF CALCITRIOL AND CORTICOSTEROID
ITRM940776A0 (en) IMAGING APPARATUS FOR OPTICALLY REVEALING THE AMOUNT OF A DEVELOPING AGENT
EP0666501A3 (en) Hardening developer for silver halide photography and development method.
MA26758A1 (en) NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES.
TNSN97191A1 (en) CIS-1- (3 ETHOXYPHENYL) -1- (4-PHENYL-PIPERAZINE-1- YL) -4- METHYLCYCLOHEXANE DIMESYLATE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION.